Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control

Atherosclerosis

Volumn 243, Issue 2, 2015, Pages 638-644

  Mueller, Daniel M ^a   Allenspach, Martina ^a   Othman, Alaa ^a,b   Saely, Christoph H ^c,d,e   Muendlein, Axel ^c,d,e   Vonbank, Alexander ^c,d,e   Drexel, Heinz ^c,d,e,f   von Eckardstein, Arnold ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF LÜBECK   (Germany)

^c Vorarlberg Institute for Vascular Investigation and Treatment VIVIT   (Austria)

^d Academic Teaching Hospital Feldkirch   (Austria)

^e PRIVATE UNIVERSITY OF THE PRINCIPALITY OF LIECHTENSTEIN   (Liechtenstein)

^f DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Betaine; Cardiovascular risk; Choline; Kidney function; Metabolic control; TMAO

Indexed keywords

BETAINE; CHOLINE; TRIMETHYLAMINE OXIDE; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; METHYLAMINE; TRIMETHYLOXAMINE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; FEMALE; HUMAN; KIDNEY FUNCTION; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METABOLIC REGULATION; METABOLIC SYNDROME X; PRIORITY JOURNAL; ANALYSIS; BLOOD; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; DIABETES MELLITUS; ELECTROSPRAY MASS SPECTROMETRY; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; KIDNEY; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; RADIOGRAPHY; REPRODUCIBILITY; TIME FACTOR; VALIDATION STUDY;

AGED; BETAINE; BIOMARKERS; BLOOD GLUCOSE; CHOLINE; CHROMATOGRAPHY, LIQUID; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; METABOLIC SYNDROME X; METHYLAMINES; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TIME FACTORS;

EID: 84946565998     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.10.091     Document Type: Article

References (44)

1. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Blaha M.J., et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014, 129. e28-e292. http://dx.doi.org/10.1161/01.cir.0000441139.02102.80.
2. Wang Z., Klipfell E., Bennett B.J., Koeth R., Levison B.S., Dugar B., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472:57-63. http://dx.doi.org/10.1038/nature09922.
3. Raymond J.A. Seasonal variations of trimethylamine oxide and urea in the blood of a cold-adapted marine teleost, the rainbow smelt. Fish. Physiol. Biochem. 1994, 13:13-22. http://dx.doi.org/10.1007/BF00004115.
4. Tang W.H., Wang Z., Levison B.S., Koeth R.A., Britt E.B., Fu X., et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 2013, 368:1575-1584. http://dx.doi.org/10.1056/NEJMoa1109400.
5. Wang Z., Tang W.H., Buffa J.A., Fu X., Britt E.B., Koeth R.A., et al. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-n-oxide. Eur. Heart J. 2014, 35:904-910. http://dx.doi.org/10.1093/eurheartj/ehu002.
6. Bennett B.J., de Aguiar Vallim T.Q., Wang Z., Shih D.M., Meng Y., Gregory J., et al. Trimethylamine-n-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013, 17:49-60. http://dx.doi.org/10.1016/j.cmet.2012.12.011.
7. Tang W.H.W., Wang Z., Wu Y., Fan Y., Koeth R.A., Hazen S. Prognostic value of elevated levels of intestinal microflora-generated metabolite trimethylamine-n-oxide in patients with heart failure: the gut hypothesis revisited. J. Am. Coll. Cardiol. 2013, 61:E750. http://dx.doi.org/10.1016/S0735-1097(13)60750%960.
8. Troseid M., Ueland T., Hov J.R., Svardal A., Gregersen I., Dahl C.P., et al. Microbiota-dependent metabolite trimethylamine-n-oxide is associated with disease severity and survival of patients with chronic heart failure. J. Intern. Med. 2015, 277:717-726. http://dx.doi.org/10.1111/joim.12328.
9. Gao X., Liu X., Xu J., Xue C., Xue Y., Wang Y. Dietary trimethylamine n-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet. J. Biosci. Bioeng. 2014, 118:476-481. http://dx.doi.org/10.1016/j.jbiosc.2014.03.001.
10. Bae S., Ulrich C.M., Neuhouser M.L., Malysheva O., Bailey L.B., Xiao L., et al. Plasma choline metabolites and colorectal cancer risk in the women's health initiative observational study. Cancer Res. 2014, 74:7442-7452. http://dx.doi.org/10.1158/0008-5472.CAN-14-1835.
11. Koeth R.A., Wang Z., Levison B.S., Buffa J.A., Org E., Sheehy B.T., et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 2013, 19:576-585. http://dx.doi.org/10.1038/nm.3145.
12. Lever M., George P.M., Slow S., Bellamy D., Young J.M., Ho M., et al. Betaine and trimethylamine-n-oxide as predictors of cardiovascular outcomes show different patterns in diabetes mellitus: an observational study. PLoS One 2014, 9:e114969. http://dx.doi.org/10.1371/journal.pone.0114969.
13. Saely C.H., Vonbank A., Rein P., Woess M., Beer S., Aczel S., et al. Alanine aminotransferase and gamma-glutamyl transferase are associated with the metabolic syndrome but not with angiographically determined coronary atherosclerosis. Clin. Chim. Acta 2008, 397:82-86. http://dx.doi.org/10.1016/j.cca.2008.07.024.
14. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann. Intern Med. 2009, 150:604-612. http://dx.doi.org/10.7326/0003-4819-150-9-200905050-00006.
15. Kidney disease Improving global outcomes (kdigo) acute kidney injury work group. Kdigo clinical practice guideline for acute kidney injury. Kidney Inter. 2012, 2:1-138. http://dx.doi.org/10.1038/kisup.2012.6.
16. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2014, 37(Suppl. 1):S81-S90. http://dx.doi.org/10.2337/dc14-S081.
17. Xiong Y., Zhao Y.Y., Goruk S., Oilund K., Field C.J., Jacobs R.L., et al. Validation of an lc-ms/ms method for the quantification of choline-related compounds and phospholipids in foods and tissues. J. Chromatogr. Anal. Technol. Biomed. Life Sci. 2012, 911:170-179. http://dx.doi.org/10.1016/j.jchromb.2012.10.038.
18. Bonfiglio R., King R.C., Olah T.V., Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun. Mass Spectrom. 1999, 13:1175-1185. http://dx.doi.org/10.1002/(SICI)1097-0231(19990630)13:12%3c1175::AID-RCM639%3e3.0.CO;2%130.
19. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on hplc-ms/ms. Anal. Chem. 2003, 75:3019-3030. http://dx.doi.org/10.1021/ac020361s.
20. Wang Z., Jones A.D. Profiling of stable isotope enrichment in specialized metabolites using liquid chromatography and multiplexed nonselective collision-induced dissociation. Anal. Chem. 2014, 86:10600-10607. http://dx.doi.org/10.1021/ac502205y.
21. Rafter J.E., Bates T.E., Bell J.D., Iles R.A. Metabolites in the developing rat liver-a proton nuclear magnetic resonance spectroscopic study. Biochim. Biophys. Acta 1991, 1074:263-269. http://dx.doi.org/10.1016/0304-4165(91)90162-A.
22. Stubbs J.R., House J.A., Ocque A.J., Zhang S., Johnson C., Kimber C., et al. Serum trimethylamine-n-oxide is elevated in ckd and correlates with coronary atherosclerosis burden. J. Am. Soc. Nephrol. 2015, http://dx.doi.org/10.1681/ASN.2014111063.
23. Rhee E.P., Clish C.B., Ghorbani A., Larson M.G., Elmariah S., McCabe E., et al. A combined epidemiologic and metabolomic approach improves ckd prediction. J. Am. Soc. Nephrol. 2013, 24:1330-1338. http://dx.doi.org/10.1681/ASN.2012101006.
24. Tang W.H., Wang Z., Kennedy D.J., Wu Y., Buffa J.A., Agatisa-Boyle B., et al. Gut microbiota-dependent trimethylamine n-oxide (tmao) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ. Res. 2015, 116:448-455. http://dx.doi.org/10.1161/CIRCRESAHA.116.305360.
25. Buchman A.L., Jenden D., Suki W.N., Roch M. Changes in plasma free and phospholipid-bound choline concentrations in chronic hemodialysis patients. J. Ren. Nutr. 2000, 10:133-138. http://dx.doi.org/10.1053/jren.2000.7411.
26. Ilcol Y.O., Donmez O., Yavuz M., Dilek K., Yurtkuran M., Ulus I.H. Free choline and phospholipid-bound choline concentrations in serum and dialysate during peritoneal dialysis in children and adults. Clin. Biochem. 2002, 35:307-313. http://dx.doi.org/10.1016/S0009-9120(02)00319-3.
27. McEntyre C.J., Lever M., Chambers S.T., George P.M., Slow S., Elmslie J.L., et al. Variation of betaine, n,n-dimethylglycine, choline, glycerophosphorylcholine, taurine and trimethylamine-n-oxide in the plasma and urine of overweight people with type 2 diabetes over a two-year period. Ann. Clin. Biochem. 2015, 52:352-360. http://dx.doi.org/10.1177/0004563214545346.
28. Mente A., Chalcraft K., Ak H., Davis A.D., Lonn E., Miller R., et al. The relationship between trimethylamine-n-oxide and prevalent cardiovascular disease in a multiethnic population living in canada. Can. J. Cardiol. 2015, http://dx.doi.org/10.1016/j.cjca.2015.06.016.
29. Danne O., Lueders C., Storm C., Frei U., Mockel M. Whole blood choline and plasma choline in acute coronary syndromes: prognostic and pathophysiological implications. Clin. Chim. Acta 2007, 383:103-109. http://dx.doi.org/10.1016/j.cca.2007.05.001.
30. Danne O., Mockel M. Choline in acute coronary syndrome: an emerging biomarker with implications for the integrated assessment of plaque vulnerability. Expert Rev. Mol. Diagn. 2010, 10:159-171. http://dx.doi.org/10.1586/erm.10.2.
31. Haissman J.M., Knudsen A., Hoel H., Kj A.A., Kristoffersen U.S., Berge R.K., et al. Microbiota-dependent marker tmao is elevated in silent ischemia but is not associated with first-time myocardial infarction in HIV infection. J. Acquir Immune Defic. Syndr. 2015, http://dx.doi.org/10.1097/QAI.0000000000000843.
32. Body R., Griffith C.A., Keevil B., McDowell G., Carley S., Ferguson J., et al. Choline for diagnosis and prognostication of acute coronary syndromes in the emergency department. Clin. Chim. Acta 2009, 404:89-94. http://dx.doi.org/10.1016/j.cca.2009.03.049.
33. Yang B., Lin H., Xu C., Liu Y., Wang H., Han H., et al. Choline produces cytoprotective effects against ischemic myocardial injuries: evidence for the role of cardiac m3 subtype muscarinic acetylcholine receptors. Cell Physiol. Biochem. 2005, 16:163-174. http://dx.doi.org/10.1159/000089842.
34. De Filippo C., Cavalieri D., Di Paola M., Ramazzotti M., Poullet J.B., Massart S., et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from europe and rural africa. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:14691-14696. http://dx.doi.org/10.1073/pnas.1005963107.
35. Mueller S., Saunier K., Hanisch C., Norin E., Alm L., Midtvedt T., et al. Differences in fecal microbiota in different european study populations in relation to age, gender, and country: a cross-sectional study. Appl. Environ. Microbiol. 2006, 72:1027-1033. http://dx.doi.org/10.1128/AEM.72.2.1027-1033.2006.
36. Yasir M., Angelakis E., Bibi F., Azhar E.I., Bachar D., Lagier J.C., et al. Comparison of the gut microbiota of people in france and saudi arabia. Nutr. Diabetes 2015, 5:e153. http://dx.doi.org/10.1038/nutd.2015.3.
37. Crichton G.E., Elias M.F., Davey A., Sauvageot N., Delagardelle C., Beissel J., et al. Cardiovascular health: a cross-national comparison between the maine syracuse study (central new york, USA) and oriscav-lux (luxembourg). BMC Public Health 2014, 14:253. http://dx.doi.org/10.1186/1471-2458-14-253.
38. Daniel C.R., Cross A.J., Koebnick C., Sinha R. Trends in meat consumption in the USA. Public Health Nutr. 2011, 14:575-583. http://dx.doi.org/10.1017/S1368980010002077.
39. Micha R., Michas G., Lajous M., Mozaffarian D. Processing of meats and cardiovascular risk: time to focus on preservatives. BMC Med. 2013, 11:136. http://dx.doi.org/10.1186/1741-7015-11-136.
40. Eisert R., Oftedal O.T., Lever M., Ramdohr S., Breier B.H., Barrell G.K. Detection of food intake in a marine mammal using marine osmolytes and their analogues as dietary biomarkers. Mar. Ecol. Prog. Ser. 2005, 300:213-228. http://dx.doi.org/10.3354/Meps300213.
41. Svensson B.G., Akesson B., Nilsson A., Paulsson K. Urinary excretion of methylamines in men with varying intake of fish from the baltic sea. J. Toxicol. Environ. Health 1994, 41:411-420. http://dx.doi.org/10.1080/15287399409531853.
42. Stone N.J. Fish consumption, fish oil, lipids, and coronary heart disease. Circulation 1996, 94:2337-2340. http://dx.doi.org/10.1161/01.CIR.94.9.2337.
43. Kris-Etherton P.M., Harris W.S., Appel L.J. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002, 106:2747-2757. http://dx.doi.org/10.1161/01.CIR.0000038493.65177.94.
44. Ussher J.R., Lopaschuk G.D., Arduini A. Gut microbiota metabolism of l-carnitine and cardiovascular risk. Atherosclerosis 2013, 231:456-461. http://dx.doi.org/10.1016/j.atherosclerosis.2013.10.013.